Plain-English translation of NCT06249178 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new tool using tiny particles called extracellular vesicles found in blood to monitor how aspirin affects pregnancy. These particles carry information about how the placenta is working and how the body is responding to the medication. By studying these particles in pregnant people taking aspirin, scientists hope to better understand whether the treatment is safe and effective.
Pregnant people are often left out of drug research because of safety concerns, making it hard to know which treatments work best during pregnancy. This study aims to fill that gap by creating new blood-based markers that can show whether this medication is helping prevent dangerous pregnancy complications like preeclampsia.
You likely qualify if…
You likely don't qualify if…
You would visit the study center multiple times during your pregnancy—typically in the second and third trimesters—to have blood samples taken. The researchers will use these blood samples to study the tiny particles and their contents to track how the medication affects your placenta and body. The study will follow you through pregnancy and may include measuring your blood pressure and reviewing your health records to see if you develop pregnancy complications.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States